Wedbush Reaffirms “Outperform” Rating for ORIC Pharmaceuticals (NASDAQ:ORIC)
Wedbush reaffirmed their outperform rating on shares of ORIC Pharmaceuticals (NASDAQ:ORIC – Free Report) in a research note released on Thursday morning,RTT News reports. They currently have a $20.00 price objective on the stock. Several other equities research analysts have also commented on ORIC. HC Wainwright reissued a “buy” rating and set a $21.00 price […]
Wedbush reaffirmed their outperform rating on shares of ORIC Pharmaceuticals (NASDAQ:ORIC – Free Report) in a research note released on Thursday morning,RTT News reports. They currently have a $20.00 price objective on the stock. Several other equities research analysts have also commented on ORIC. HC Wainwright reissued a “buy” rating and set a $21.00 price […]
